キッセイ薬品工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4547/E00962 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/02/14 | 日証協 | 163,317株 | +17.85% | 49,991株 | -43.69% | 662,538株 | +0.49% | 29,753株 | -56.94% |
2020/02/07 | 日証協 | 138,580株 | +2.96% | 88,780株 | -6.04% | 659,339株 | +3% | 69,095株 | -86.75% |
2020/01/31 | 日証協 | 134,595株 | -13.65% | 94,483株 | +67.23% | 640,133株 | -3.89% | 521,400株 | +848.29% |
2020/01/24 | 日証協 | 155,879株 | -10.21% | 56,500株 | -15.16% | 666,021株 | -5.39% | 54,983株 | +31.22% |
2020/01/17 | 日証協 | 173,600株 | +8.92% | 66,595株 | +26.37% | 703,942株 | +0.53% | 41,900株 | -0.95% |
2020/01/10 | 日証協 | 159,379株 | -6.86% | 52,700株 | +589.43% | 700,230株 | +2.75% | 42,300株 | -91.5% |
2019/12/30 | 日証協 | 171,123株 | -8.3% | 7,644株 | -64.59% | 681,522株 | -2.36% | 497,700株 | +1882.87% |
2019/12/27 | 日証協 | 186,611株 | -23.52% | 21,588株 | -70.54% | 698,010株 | -4.45% | 25,100株 | -62.92% |
2019/12/20 | 日証協 | 244,011株 | +2.47% | 73,288株 | -25.1% | 730,510株 | -1.36% | 67,700株 | -28.67% |
2019/12/13 | 日証協 | 238,132株 | +16.12% | 97,846株 | +149.41% | 740,610株 | +0.98% | 94,908株 | +222.84% |
2019/12/06 | 日証協 | 205,067株 | -5.66% | 39,231株 | -5.84% | 733,408株 | -6.93% | 29,398株 | -94.23% |
2019/11/29 | 日証協 | 217,375株 | -7.33% | 41,666株 | -3.05% | 788,016株 | -1.99% | 509,816株 | +1043.62% |
2019/11/22 | 日証協 | 234,557株 | -2.01% | 42,979株 | -38.67% | 803,979株 | -2.08% | 44,579株 | +2.95% |
2019/11/15 | 日証協 | 239,357株 | +1.99% | 70,079株 | +4.94% | 821,079株 | -3.4% | 43,300株 | +34.43% |
2019/11/08 | 日証協 | 234,678株 | -1.86% | 66,777株 | +13.37% | 849,979株 | -3.54% | 32,211株 | -94.44% |
2019/11/01 | 日証協 | 239,119株 | +1.27% | 58,900株 | +57.15% | 881,205株 | +0.02% | 579,588株 | +2204.71% |
2019/10/25 | 日証協 | 236,116株 | -16.51% | 37,480株 | -62.29% | 881,020株 | -7.59% | 25,148株 | -75.77% |
2019/10/18 | 日証協 | 282,795株 | +2.87% | 99,392株 | -32.18% | 953,421株 | -1.79% | 103,790株 | +49.39% |
2019/10/11 | 日証協 | 274,903株 | +18.16% | 146,560株 | -30.65% | 970,829株 | +0.93% | 69,477株 | -91.25% |
※株式分割は考慮していませんのでご注意ください。
Page Top